Global Anti-tuberculosis Therapeutics Market Growth (Status and Outlook) 2025-2031
According to this study, the global Anti-tuberculosis Therapeutics market size will reach US$ million by 2031.
Tuberculosis (TB) is a disease affecting the population across the world. Although tuberculosis is a curable disease, it still remains one of the most common causes of death among adults, particularly in the emerging economies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Anti-tuberculosis Therapeutics Industry Forecast” looks at past sales and reviews total world Anti-tuberculosis Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-tuberculosis Therapeutics sales for 2025 through 2031. With Anti-tuberculosis Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-tuberculosis Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Anti-tuberculosis Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anti-tuberculosis Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-tuberculosis Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-tuberculosis Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-tuberculosis Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-tuberculosis Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Tuberculosis (TB) is a disease affecting the population across the world. Although tuberculosis is a curable disease, it still remains one of the most common causes of death among adults, particularly in the emerging economies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Anti-tuberculosis Therapeutics Industry Forecast” looks at past sales and reviews total world Anti-tuberculosis Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-tuberculosis Therapeutics sales for 2025 through 2031. With Anti-tuberculosis Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-tuberculosis Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Anti-tuberculosis Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anti-tuberculosis Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-tuberculosis Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-tuberculosis Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-tuberculosis Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-tuberculosis Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Isoniazid
- Rifampin
- Ethambutol
- Pyrazinamide
- Otherr
- Hospitals and Clinics
- Government Agencies
- Non-Profit Organizations
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lupin
- Macleods Pharmaceuticals
- Otsuka Pharmaceutical
- Johnson & Johnson
- Pfizer
- Novartis
- Abbott
- AstraZeneca
- Bayer
- Eli Lilly
- GlaxoSmithKline
- Merck
- Sanofi
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-tuberculosis Therapeutics Market Size (2020-2031)
2.1.2 Anti-tuberculosis Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Anti-tuberculosis Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Anti-tuberculosis Therapeutics Segment by Type
2.2.1 Isoniazid
2.2.2 Rifampin
2.2.3 Ethambutol
2.2.4 Pyrazinamide
2.2.5 Otherr
2.3 Anti-tuberculosis Therapeutics Market Size by Type
2.3.1 Anti-tuberculosis Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Anti-tuberculosis Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Anti-tuberculosis Therapeutics Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Government Agencies
2.4.3 Non-Profit Organizations
2.4.4 Others
2.5 Anti-tuberculosis Therapeutics Market Size by Application
2.5.1 Anti-tuberculosis Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Anti-tuberculosis Therapeutics Market Size Market Share by Application (2020-2025)
3 ANTI-TUBERCULOSIS THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Anti-tuberculosis Therapeutics Market Size Market Share by Player
3.1.1 Global Anti-tuberculosis Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Anti-tuberculosis Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Anti-tuberculosis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTI-TUBERCULOSIS THERAPEUTICS BY REGION
4.1 Anti-tuberculosis Therapeutics Market Size by Region (2020-2025)
4.2 Global Anti-tuberculosis Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-tuberculosis Therapeutics Market Size Growth (2020-2025)
4.4 APAC Anti-tuberculosis Therapeutics Market Size Growth (2020-2025)
4.5 Europe Anti-tuberculosis Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Anti-tuberculosis Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Anti-tuberculosis Therapeutics Market Size by Country (2020-2025)
5.2 Americas Anti-tuberculosis Therapeutics Market Size by Type (2020-2025)
5.3 Americas Anti-tuberculosis Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-tuberculosis Therapeutics Market Size by Region (2020-2025)
6.2 APAC Anti-tuberculosis Therapeutics Market Size by Type (2020-2025)
6.3 APAC Anti-tuberculosis Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Anti-tuberculosis Therapeutics Market Size by Country (2020-2025)
7.2 Europe Anti-tuberculosis Therapeutics Market Size by Type (2020-2025)
7.3 Europe Anti-tuberculosis Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-tuberculosis Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTI-TUBERCULOSIS THERAPEUTICS MARKET FORECAST
10.1 Global Anti-tuberculosis Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Anti-tuberculosis Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Anti-tuberculosis Therapeutics Forecast
10.1.3 APAC Anti-tuberculosis Therapeutics Forecast
10.1.4 Europe Anti-tuberculosis Therapeutics Forecast
10.1.5 Middle East & Africa Anti-tuberculosis Therapeutics Forecast
10.2 Americas Anti-tuberculosis Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Anti-tuberculosis Therapeutics Forecast
10.2.2 Canada Market Anti-tuberculosis Therapeutics Forecast
10.2.3 Mexico Market Anti-tuberculosis Therapeutics Forecast
10.2.4 Brazil Market Anti-tuberculosis Therapeutics Forecast
10.3 APAC Anti-tuberculosis Therapeutics Forecast by Region (2026-2031)
10.3.1 China Anti-tuberculosis Therapeutics Market Forecast
10.3.2 Japan Market Anti-tuberculosis Therapeutics Forecast
10.3.3 Korea Market Anti-tuberculosis Therapeutics Forecast
10.3.4 Southeast Asia Market Anti-tuberculosis Therapeutics Forecast
10.3.5 India Market Anti-tuberculosis Therapeutics Forecast
10.3.6 Australia Market Anti-tuberculosis Therapeutics Forecast
10.4 Europe Anti-tuberculosis Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Anti-tuberculosis Therapeutics Forecast
10.4.2 France Market Anti-tuberculosis Therapeutics Forecast
10.4.3 UK Market Anti-tuberculosis Therapeutics Forecast
10.4.4 Italy Market Anti-tuberculosis Therapeutics Forecast
10.4.5 Russia Market Anti-tuberculosis Therapeutics Forecast
10.5 Middle East & Africa Anti-tuberculosis Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Anti-tuberculosis Therapeutics Forecast
10.5.2 South Africa Market Anti-tuberculosis Therapeutics Forecast
10.5.3 Israel Market Anti-tuberculosis Therapeutics Forecast
10.5.4 Turkey Market Anti-tuberculosis Therapeutics Forecast
10.6 Global Anti-tuberculosis Therapeutics Forecast by Type (2026-2031)
10.7 Global Anti-tuberculosis Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Anti-tuberculosis Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lupin
11.1.1 Lupin Company Information
11.1.2 Lupin Anti-tuberculosis Therapeutics Product Offered
11.1.3 Lupin Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Lupin Main Business Overview
11.1.5 Lupin Latest Developments
11.2 Macleods Pharmaceuticals
11.2.1 Macleods Pharmaceuticals Company Information
11.2.2 Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Product Offered
11.2.3 Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Macleods Pharmaceuticals Main Business Overview
11.2.5 Macleods Pharmaceuticals Latest Developments
11.3 Otsuka Pharmaceutical
11.3.1 Otsuka Pharmaceutical Company Information
11.3.2 Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Product Offered
11.3.3 Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Otsuka Pharmaceutical Main Business Overview
11.3.5 Otsuka Pharmaceutical Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Anti-tuberculosis Therapeutics Product Offered
11.4.3 Johnson & Johnson Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Anti-tuberculosis Therapeutics Product Offered
11.5.3 Pfizer Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Anti-tuberculosis Therapeutics Product Offered
11.6.3 Novartis Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Abbott
11.7.1 Abbott Company Information
11.7.2 Abbott Anti-tuberculosis Therapeutics Product Offered
11.7.3 Abbott Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Abbott Main Business Overview
11.7.5 Abbott Latest Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Anti-tuberculosis Therapeutics Product Offered
11.8.3 AstraZeneca Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 AstraZeneca Main Business Overview
11.8.5 AstraZeneca Latest Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Anti-tuberculosis Therapeutics Product Offered
11.9.3 Bayer Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Bayer Main Business Overview
11.9.5 Bayer Latest Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Information
11.10.2 Eli Lilly Anti-tuberculosis Therapeutics Product Offered
11.10.3 Eli Lilly Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Eli Lilly Main Business Overview
11.10.5 Eli Lilly Latest Developments
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Information
11.11.2 GlaxoSmithKline Anti-tuberculosis Therapeutics Product Offered
11.11.3 GlaxoSmithKline Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 GlaxoSmithKline Main Business Overview
11.11.5 GlaxoSmithKline Latest Developments
11.12 Merck
11.12.1 Merck Company Information
11.12.2 Merck Anti-tuberculosis Therapeutics Product Offered
11.12.3 Merck Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Merck Main Business Overview
11.12.5 Merck Latest Developments
11.13 Sanofi
11.13.1 Sanofi Company Information
11.13.2 Sanofi Anti-tuberculosis Therapeutics Product Offered
11.13.3 Sanofi Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Sanofi Main Business Overview
11.13.5 Sanofi Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-tuberculosis Therapeutics Market Size (2020-2031)
2.1.2 Anti-tuberculosis Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Anti-tuberculosis Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Anti-tuberculosis Therapeutics Segment by Type
2.2.1 Isoniazid
2.2.2 Rifampin
2.2.3 Ethambutol
2.2.4 Pyrazinamide
2.2.5 Otherr
2.3 Anti-tuberculosis Therapeutics Market Size by Type
2.3.1 Anti-tuberculosis Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Anti-tuberculosis Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Anti-tuberculosis Therapeutics Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Government Agencies
2.4.3 Non-Profit Organizations
2.4.4 Others
2.5 Anti-tuberculosis Therapeutics Market Size by Application
2.5.1 Anti-tuberculosis Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Anti-tuberculosis Therapeutics Market Size Market Share by Application (2020-2025)
3 ANTI-TUBERCULOSIS THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Anti-tuberculosis Therapeutics Market Size Market Share by Player
3.1.1 Global Anti-tuberculosis Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Anti-tuberculosis Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Anti-tuberculosis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTI-TUBERCULOSIS THERAPEUTICS BY REGION
4.1 Anti-tuberculosis Therapeutics Market Size by Region (2020-2025)
4.2 Global Anti-tuberculosis Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-tuberculosis Therapeutics Market Size Growth (2020-2025)
4.4 APAC Anti-tuberculosis Therapeutics Market Size Growth (2020-2025)
4.5 Europe Anti-tuberculosis Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Anti-tuberculosis Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Anti-tuberculosis Therapeutics Market Size by Country (2020-2025)
5.2 Americas Anti-tuberculosis Therapeutics Market Size by Type (2020-2025)
5.3 Americas Anti-tuberculosis Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-tuberculosis Therapeutics Market Size by Region (2020-2025)
6.2 APAC Anti-tuberculosis Therapeutics Market Size by Type (2020-2025)
6.3 APAC Anti-tuberculosis Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Anti-tuberculosis Therapeutics Market Size by Country (2020-2025)
7.2 Europe Anti-tuberculosis Therapeutics Market Size by Type (2020-2025)
7.3 Europe Anti-tuberculosis Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-tuberculosis Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTI-TUBERCULOSIS THERAPEUTICS MARKET FORECAST
10.1 Global Anti-tuberculosis Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Anti-tuberculosis Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Anti-tuberculosis Therapeutics Forecast
10.1.3 APAC Anti-tuberculosis Therapeutics Forecast
10.1.4 Europe Anti-tuberculosis Therapeutics Forecast
10.1.5 Middle East & Africa Anti-tuberculosis Therapeutics Forecast
10.2 Americas Anti-tuberculosis Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Anti-tuberculosis Therapeutics Forecast
10.2.2 Canada Market Anti-tuberculosis Therapeutics Forecast
10.2.3 Mexico Market Anti-tuberculosis Therapeutics Forecast
10.2.4 Brazil Market Anti-tuberculosis Therapeutics Forecast
10.3 APAC Anti-tuberculosis Therapeutics Forecast by Region (2026-2031)
10.3.1 China Anti-tuberculosis Therapeutics Market Forecast
10.3.2 Japan Market Anti-tuberculosis Therapeutics Forecast
10.3.3 Korea Market Anti-tuberculosis Therapeutics Forecast
10.3.4 Southeast Asia Market Anti-tuberculosis Therapeutics Forecast
10.3.5 India Market Anti-tuberculosis Therapeutics Forecast
10.3.6 Australia Market Anti-tuberculosis Therapeutics Forecast
10.4 Europe Anti-tuberculosis Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Anti-tuberculosis Therapeutics Forecast
10.4.2 France Market Anti-tuberculosis Therapeutics Forecast
10.4.3 UK Market Anti-tuberculosis Therapeutics Forecast
10.4.4 Italy Market Anti-tuberculosis Therapeutics Forecast
10.4.5 Russia Market Anti-tuberculosis Therapeutics Forecast
10.5 Middle East & Africa Anti-tuberculosis Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Anti-tuberculosis Therapeutics Forecast
10.5.2 South Africa Market Anti-tuberculosis Therapeutics Forecast
10.5.3 Israel Market Anti-tuberculosis Therapeutics Forecast
10.5.4 Turkey Market Anti-tuberculosis Therapeutics Forecast
10.6 Global Anti-tuberculosis Therapeutics Forecast by Type (2026-2031)
10.7 Global Anti-tuberculosis Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Anti-tuberculosis Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lupin
11.1.1 Lupin Company Information
11.1.2 Lupin Anti-tuberculosis Therapeutics Product Offered
11.1.3 Lupin Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Lupin Main Business Overview
11.1.5 Lupin Latest Developments
11.2 Macleods Pharmaceuticals
11.2.1 Macleods Pharmaceuticals Company Information
11.2.2 Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Product Offered
11.2.3 Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Macleods Pharmaceuticals Main Business Overview
11.2.5 Macleods Pharmaceuticals Latest Developments
11.3 Otsuka Pharmaceutical
11.3.1 Otsuka Pharmaceutical Company Information
11.3.2 Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Product Offered
11.3.3 Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Otsuka Pharmaceutical Main Business Overview
11.3.5 Otsuka Pharmaceutical Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Anti-tuberculosis Therapeutics Product Offered
11.4.3 Johnson & Johnson Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Anti-tuberculosis Therapeutics Product Offered
11.5.3 Pfizer Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Anti-tuberculosis Therapeutics Product Offered
11.6.3 Novartis Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Abbott
11.7.1 Abbott Company Information
11.7.2 Abbott Anti-tuberculosis Therapeutics Product Offered
11.7.3 Abbott Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Abbott Main Business Overview
11.7.5 Abbott Latest Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Anti-tuberculosis Therapeutics Product Offered
11.8.3 AstraZeneca Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 AstraZeneca Main Business Overview
11.8.5 AstraZeneca Latest Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Anti-tuberculosis Therapeutics Product Offered
11.9.3 Bayer Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Bayer Main Business Overview
11.9.5 Bayer Latest Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Information
11.10.2 Eli Lilly Anti-tuberculosis Therapeutics Product Offered
11.10.3 Eli Lilly Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Eli Lilly Main Business Overview
11.10.5 Eli Lilly Latest Developments
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Information
11.11.2 GlaxoSmithKline Anti-tuberculosis Therapeutics Product Offered
11.11.3 GlaxoSmithKline Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 GlaxoSmithKline Main Business Overview
11.11.5 GlaxoSmithKline Latest Developments
11.12 Merck
11.12.1 Merck Company Information
11.12.2 Merck Anti-tuberculosis Therapeutics Product Offered
11.12.3 Merck Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Merck Main Business Overview
11.12.5 Merck Latest Developments
11.13 Sanofi
11.13.1 Sanofi Company Information
11.13.2 Sanofi Anti-tuberculosis Therapeutics Product Offered
11.13.3 Sanofi Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Sanofi Main Business Overview
11.13.5 Sanofi Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-tuberculosis Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Anti-tuberculosis Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Isoniazid
Table 4. Major Players of Rifampin
Table 5. Major Players of Ethambutol
Table 6. Major Players of Pyrazinamide
Table 7. Major Players of Otherr
Table 8. Anti-tuberculosis Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Anti-tuberculosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Anti-tuberculosis Therapeutics Market Size Market Share by Type (2020-2025)
Table 11. Anti-tuberculosis Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Anti-tuberculosis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Anti-tuberculosis Therapeutics Market Size Market Share by Application (2020-2025)
Table 14. Global Anti-tuberculosis Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Anti-tuberculosis Therapeutics Revenue Market Share by Player (2020-2025)
Table 16. Anti-tuberculosis Therapeutics Key Players Head office and Products Offered
Table 17. Anti-tuberculosis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Anti-tuberculosis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Anti-tuberculosis Therapeutics Market Size Market Share by Region (2020-2025)
Table 22. Global Anti-tuberculosis Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Anti-tuberculosis Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Anti-tuberculosis Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Anti-tuberculosis Therapeutics Market Size Market Share by Country (2020-2025)
Table 26. Americas Anti-tuberculosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Anti-tuberculosis Therapeutics Market Size Market Share by Type (2020-2025)
Table 28. Americas Anti-tuberculosis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Anti-tuberculosis Therapeutics Market Size Market Share by Application (2020-2025)
Table 30. APAC Anti-tuberculosis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Anti-tuberculosis Therapeutics Market Size Market Share by Region (2020-2025)
Table 32. APAC Anti-tuberculosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Anti-tuberculosis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Anti-tuberculosis Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Anti-tuberculosis Therapeutics Market Size Market Share by Country (2020-2025)
Table 36. Europe Anti-tuberculosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Anti-tuberculosis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Anti-tuberculosis Therapeutics
Table 42. Key Market Challenges & Risks of Anti-tuberculosis Therapeutics
Table 43. Key Industry Trends of Anti-tuberculosis Therapeutics
Table 44. Global Anti-tuberculosis Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Anti-tuberculosis Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Anti-tuberculosis Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Anti-tuberculosis Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Lupin Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 49. Lupin Anti-tuberculosis Therapeutics Product Offered
Table 50. Lupin Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Lupin Main Business
Table 52. Lupin Latest Developments
Table 53. Macleods Pharmaceuticals Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 54. Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Product Offered
Table 55. Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Macleods Pharmaceuticals Main Business
Table 57. Macleods Pharmaceuticals Latest Developments
Table 58. Otsuka Pharmaceutical Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 59. Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Product Offered
Table 60. Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Otsuka Pharmaceutical Main Business
Table 62. Otsuka Pharmaceutical Latest Developments
Table 63. Johnson & Johnson Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 64. Johnson & Johnson Anti-tuberculosis Therapeutics Product Offered
Table 65. Johnson & Johnson Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Johnson & Johnson Main Business
Table 67. Johnson & Johnson Latest Developments
Table 68. Pfizer Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 69. Pfizer Anti-tuberculosis Therapeutics Product Offered
Table 70. Pfizer Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Pfizer Main Business
Table 72. Pfizer Latest Developments
Table 73. Novartis Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 74. Novartis Anti-tuberculosis Therapeutics Product Offered
Table 75. Novartis Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Novartis Main Business
Table 77. Novartis Latest Developments
Table 78. Abbott Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 79. Abbott Anti-tuberculosis Therapeutics Product Offered
Table 80. Abbott Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Abbott Main Business
Table 82. Abbott Latest Developments
Table 83. AstraZeneca Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 84. AstraZeneca Anti-tuberculosis Therapeutics Product Offered
Table 85. AstraZeneca Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. AstraZeneca Main Business
Table 87. AstraZeneca Latest Developments
Table 88. Bayer Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 89. Bayer Anti-tuberculosis Therapeutics Product Offered
Table 90. Bayer Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Bayer Main Business
Table 92. Bayer Latest Developments
Table 93. Eli Lilly Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 94. Eli Lilly Anti-tuberculosis Therapeutics Product Offered
Table 95. Eli Lilly Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Eli Lilly Main Business
Table 97. Eli Lilly Latest Developments
Table 98. GlaxoSmithKline Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 99. GlaxoSmithKline Anti-tuberculosis Therapeutics Product Offered
Table 100. GlaxoSmithKline Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. GlaxoSmithKline Main Business
Table 102. GlaxoSmithKline Latest Developments
Table 103. Merck Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 104. Merck Anti-tuberculosis Therapeutics Product Offered
Table 105. Merck Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. Merck Main Business
Table 107. Merck Latest Developments
Table 108. Sanofi Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 109. Sanofi Anti-tuberculosis Therapeutics Product Offered
Table 110. Sanofi Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. Sanofi Main Business
Table 112. Sanofi Latest Developments
Table 1. Anti-tuberculosis Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Anti-tuberculosis Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Isoniazid
Table 4. Major Players of Rifampin
Table 5. Major Players of Ethambutol
Table 6. Major Players of Pyrazinamide
Table 7. Major Players of Otherr
Table 8. Anti-tuberculosis Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Anti-tuberculosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Anti-tuberculosis Therapeutics Market Size Market Share by Type (2020-2025)
Table 11. Anti-tuberculosis Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Anti-tuberculosis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Anti-tuberculosis Therapeutics Market Size Market Share by Application (2020-2025)
Table 14. Global Anti-tuberculosis Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Anti-tuberculosis Therapeutics Revenue Market Share by Player (2020-2025)
Table 16. Anti-tuberculosis Therapeutics Key Players Head office and Products Offered
Table 17. Anti-tuberculosis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Anti-tuberculosis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Anti-tuberculosis Therapeutics Market Size Market Share by Region (2020-2025)
Table 22. Global Anti-tuberculosis Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Anti-tuberculosis Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Anti-tuberculosis Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Anti-tuberculosis Therapeutics Market Size Market Share by Country (2020-2025)
Table 26. Americas Anti-tuberculosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Anti-tuberculosis Therapeutics Market Size Market Share by Type (2020-2025)
Table 28. Americas Anti-tuberculosis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Anti-tuberculosis Therapeutics Market Size Market Share by Application (2020-2025)
Table 30. APAC Anti-tuberculosis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Anti-tuberculosis Therapeutics Market Size Market Share by Region (2020-2025)
Table 32. APAC Anti-tuberculosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Anti-tuberculosis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Anti-tuberculosis Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Anti-tuberculosis Therapeutics Market Size Market Share by Country (2020-2025)
Table 36. Europe Anti-tuberculosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Anti-tuberculosis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Anti-tuberculosis Therapeutics
Table 42. Key Market Challenges & Risks of Anti-tuberculosis Therapeutics
Table 43. Key Industry Trends of Anti-tuberculosis Therapeutics
Table 44. Global Anti-tuberculosis Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Anti-tuberculosis Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Anti-tuberculosis Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Anti-tuberculosis Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Lupin Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 49. Lupin Anti-tuberculosis Therapeutics Product Offered
Table 50. Lupin Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Lupin Main Business
Table 52. Lupin Latest Developments
Table 53. Macleods Pharmaceuticals Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 54. Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Product Offered
Table 55. Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Macleods Pharmaceuticals Main Business
Table 57. Macleods Pharmaceuticals Latest Developments
Table 58. Otsuka Pharmaceutical Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 59. Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Product Offered
Table 60. Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Otsuka Pharmaceutical Main Business
Table 62. Otsuka Pharmaceutical Latest Developments
Table 63. Johnson & Johnson Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 64. Johnson & Johnson Anti-tuberculosis Therapeutics Product Offered
Table 65. Johnson & Johnson Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Johnson & Johnson Main Business
Table 67. Johnson & Johnson Latest Developments
Table 68. Pfizer Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 69. Pfizer Anti-tuberculosis Therapeutics Product Offered
Table 70. Pfizer Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Pfizer Main Business
Table 72. Pfizer Latest Developments
Table 73. Novartis Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 74. Novartis Anti-tuberculosis Therapeutics Product Offered
Table 75. Novartis Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Novartis Main Business
Table 77. Novartis Latest Developments
Table 78. Abbott Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 79. Abbott Anti-tuberculosis Therapeutics Product Offered
Table 80. Abbott Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Abbott Main Business
Table 82. Abbott Latest Developments
Table 83. AstraZeneca Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 84. AstraZeneca Anti-tuberculosis Therapeutics Product Offered
Table 85. AstraZeneca Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. AstraZeneca Main Business
Table 87. AstraZeneca Latest Developments
Table 88. Bayer Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 89. Bayer Anti-tuberculosis Therapeutics Product Offered
Table 90. Bayer Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Bayer Main Business
Table 92. Bayer Latest Developments
Table 93. Eli Lilly Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 94. Eli Lilly Anti-tuberculosis Therapeutics Product Offered
Table 95. Eli Lilly Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Eli Lilly Main Business
Table 97. Eli Lilly Latest Developments
Table 98. GlaxoSmithKline Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 99. GlaxoSmithKline Anti-tuberculosis Therapeutics Product Offered
Table 100. GlaxoSmithKline Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. GlaxoSmithKline Main Business
Table 102. GlaxoSmithKline Latest Developments
Table 103. Merck Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 104. Merck Anti-tuberculosis Therapeutics Product Offered
Table 105. Merck Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. Merck Main Business
Table 107. Merck Latest Developments
Table 108. Sanofi Details, Company Type, Anti-tuberculosis Therapeutics Area Served and Its Competitors
Table 109. Sanofi Anti-tuberculosis Therapeutics Product Offered
Table 110. Sanofi Anti-tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. Sanofi Main Business
Table 112. Sanofi Latest Developments
LIST OF FIGURES
Figure 1. Anti-tuberculosis Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-tuberculosis Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Anti-tuberculosis Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Anti-tuberculosis Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Anti-tuberculosis Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Anti-tuberculosis Therapeutics Market Size Market Share by Type in 2024
Figure 10. Anti-tuberculosis Therapeutics in Hospitals and Clinics
Figure 11. Global Anti-tuberculosis Therapeutics Market: Hospitals and Clinics (2020-2025) & ($ millions)
Figure 12. Anti-tuberculosis Therapeutics in Government Agencies
Figure 13. Global Anti-tuberculosis Therapeutics Market: Government Agencies (2020-2025) & ($ millions)
Figure 14. Anti-tuberculosis Therapeutics in Non-Profit Organizations
Figure 15. Global Anti-tuberculosis Therapeutics Market: Non-Profit Organizations (2020-2025) & ($ millions)
Figure 16. Anti-tuberculosis Therapeutics in Others
Figure 17. Global Anti-tuberculosis Therapeutics Market: Others (2020-2025) & ($ millions)
Figure 18. Global Anti-tuberculosis Therapeutics Market Size Market Share by Application in 2024
Figure 19. Global Anti-tuberculosis Therapeutics Revenue Market Share by Player in 2024
Figure 20. Global Anti-tuberculosis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 21. Americas Anti-tuberculosis Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. APAC Anti-tuberculosis Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Europe Anti-tuberculosis Therapeutics Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Anti-tuberculosis Therapeutics Market Size 2020-2025 ($ millions)
Figure 25. Americas Anti-tuberculosis Therapeutics Value Market Share by Country in 2024
Figure 26. United States Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Anti-tuberculosis Therapeutics Market Size Market Share by Region in 2024
Figure 31. APAC Anti-tuberculosis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 32. APAC Anti-tuberculosis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 33. China Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. India Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Anti-tuberculosis Therapeutics Market Size Market Share by Country in 2024
Figure 40. Europe Anti-tuberculosis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 41. Europe Anti-tuberculosis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 42. Germany Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. France Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Anti-tuberculosis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Anti-tuberculosis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Anti-tuberculosis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. APAC Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. Europe Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. United States Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Canada Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. Mexico Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Brazil Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. China Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Japan Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. Korea Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. India Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Australia Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. Germany Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. France Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. UK Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Italy Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. Russia Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Egypt Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. South Africa Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Israel Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 77. Turkey Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 78. Global Anti-tuberculosis Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Anti-tuberculosis Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 1. Anti-tuberculosis Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-tuberculosis Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Anti-tuberculosis Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Anti-tuberculosis Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Anti-tuberculosis Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Anti-tuberculosis Therapeutics Market Size Market Share by Type in 2024
Figure 10. Anti-tuberculosis Therapeutics in Hospitals and Clinics
Figure 11. Global Anti-tuberculosis Therapeutics Market: Hospitals and Clinics (2020-2025) & ($ millions)
Figure 12. Anti-tuberculosis Therapeutics in Government Agencies
Figure 13. Global Anti-tuberculosis Therapeutics Market: Government Agencies (2020-2025) & ($ millions)
Figure 14. Anti-tuberculosis Therapeutics in Non-Profit Organizations
Figure 15. Global Anti-tuberculosis Therapeutics Market: Non-Profit Organizations (2020-2025) & ($ millions)
Figure 16. Anti-tuberculosis Therapeutics in Others
Figure 17. Global Anti-tuberculosis Therapeutics Market: Others (2020-2025) & ($ millions)
Figure 18. Global Anti-tuberculosis Therapeutics Market Size Market Share by Application in 2024
Figure 19. Global Anti-tuberculosis Therapeutics Revenue Market Share by Player in 2024
Figure 20. Global Anti-tuberculosis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 21. Americas Anti-tuberculosis Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. APAC Anti-tuberculosis Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Europe Anti-tuberculosis Therapeutics Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Anti-tuberculosis Therapeutics Market Size 2020-2025 ($ millions)
Figure 25. Americas Anti-tuberculosis Therapeutics Value Market Share by Country in 2024
Figure 26. United States Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Anti-tuberculosis Therapeutics Market Size Market Share by Region in 2024
Figure 31. APAC Anti-tuberculosis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 32. APAC Anti-tuberculosis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 33. China Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. India Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Anti-tuberculosis Therapeutics Market Size Market Share by Country in 2024
Figure 40. Europe Anti-tuberculosis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 41. Europe Anti-tuberculosis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 42. Germany Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. France Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Anti-tuberculosis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Anti-tuberculosis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Anti-tuberculosis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Anti-tuberculosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. APAC Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. Europe Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. United States Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Canada Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. Mexico Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Brazil Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. China Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Japan Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. Korea Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. India Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Australia Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. Germany Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. France Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. UK Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Italy Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. Russia Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Egypt Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. South Africa Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Israel Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 77. Turkey Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 78. Global Anti-tuberculosis Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Anti-tuberculosis Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Anti-tuberculosis Therapeutics Market Size 2026-2031 ($ millions)
More Publications
Global Rapid Coagulation Testing Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
91 pages
Global Gastroparesis Treatment Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
99 pages
Global Hemophilia Gene Therapy Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
March 2025
91 pages
Global Seaweed Powder Market Growth 2025-2031
US$ 3,660.00
January 2025
119 pages
